Perfect for planning, doodling, and more
Handling Missed Doses Travel is unpredictable
1 This study is the first to evaluate the association between GLP-1 agonist use and key clinical outcomes, including anemia, transfusion, hospitalization, and mortality, in a large-scale analysis of patients with celiac disease. Investigators sourced data for the present study from TriNetX and identified patients with celiac disease using ICD-10 codes, stratifying them according to documented exposure to GLP-1 agonists, including semaglutide, dulaglutide, liraglutide, or exenatide
Does semaglutide cause gallstones
00:06:23 Vickie Danaher But there arent any head-to-head trials yet
Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Sattar N, Brueckmann M, Jamal W, Cotton D, et al